Skip to main content
Top
Published in: Israel Journal of Health Policy Research 1/2018

Open Access 01-12-2018 | Integrative article

Clinical and other specialty services offered by pharmacists in the community: the international arena and Israel

Authors: Eyal Schwartzberg, Joseph P. Nathan, Sivan Avron, Eli Marom

Published in: Israel Journal of Health Policy Research | Issue 1/2018

Login to get access

Abstract

The community pharmacy setting is a venue that is readily accessible to the public. In addition, it is staffed by a pharmacist, who is a healthcare provider, trained and capable of delivering comprehensive pharmaceutical care. As such, community pharmacists have a colossal opportunity to serve as key contributors to patients’ health by ensuring appropriate use of medications, preventing medication misadventures, identifying drug-therapy needs, as well as by being involved in disease management, screening, and prevention programs. This unique position gives the pharmacist the privilege and duty to serve patients in roles other than solely that of the stereotypical drug dispenser.
Worldwide, as well as in Israel, pharmacists already offer a variety of pharmaceutical services and tend to patients’ and the healthcare system’s needs. This article provides examples of professional, clinical or other specialty services offered by community pharmacists around the world and in Israel and describes these interventions as well as the evidence for their efficacy. Examples of such activities which were recently introduced to the Israeli pharmacy landscape due to legislative changes which expanded the pharmacist’s scope of practice include emergency supply of medications, pharmacists prescribing, and influenza vaccination. Despite the progress already made, further expansion of these opportunities is warranted but challenging. Independent prescribing, as practiced in the United Kingdom or collaborative drug therapy management programs, as practiced in the United States, expansion of vaccination programs, or wide-spread recognition and reimbursement for medication therapy management (MTM) programs are unrealized opportunities. Obstacles such as time constraints, lack of financial incentives, inadequate facilities and technology, and lack of professional buy-in, and suggested means for overcoming these challenges are also discussed.
Appendix
Available only for authorised users
Footnotes
1
According to the Health Ministry [38], a chronic patient is defined either by the diagnosis of a chronic illness or by the medication the patient is taking; the medication can be any medication from a given list, or any other medication prescribed for over six months.
 
2
According to 2007 NHLBI Guidelines for the Diagnosis and Treatment of Asthma Expert Panel.
 
3
COPD stages by the GOLD system, stage III defined as: FEV1/FVC ratio less than 70%, FEV1 30% to less than 50% predicted value, may have chronic symptoms and treated among other treatments with corticosteroids.
 
Literature
5.
go back to reference Schwartzberg E, Nathan JP, Rosen B, Marom E. Pharmacy in Israel. Am J Health Syst Pharm. 2018;75(1):e57–61.CrossRef Schwartzberg E, Nathan JP, Rosen B, Marom E. Pharmacy in Israel. Am J Health Syst Pharm. 2018;75(1):e57–61.CrossRef
9.
go back to reference Foppe van Mil JW, Schulz MA. Review of pharmaceutical care in community pharmacy in Europe. Harvard Health Policy Review. 2006;7(1):155–68. Foppe van Mil JW, Schulz MA. Review of pharmaceutical care in community pharmacy in Europe. Harvard Health Policy Review. 2006;7(1):155–68.
10.
go back to reference Shord SS, Schwinghammer TL, Badowski M, Banderas J, Burton ME, Chapleau CA, et al. Desired professional development pathways for clinical pharmacists. Pharmacotherapy. 2013;33(4):e34–42.CrossRef Shord SS, Schwinghammer TL, Badowski M, Banderas J, Burton ME, Chapleau CA, et al. Desired professional development pathways for clinical pharmacists. Pharmacotherapy. 2013;33(4):e34–42.CrossRef
11.
go back to reference Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother. 2007;41(5):861–8.CrossRef Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother. 2007;41(5):861–8.CrossRef
17.
go back to reference Twigg MJ, Wright D, Barton GR, Thornley T, Kerr C. The four or more medicines (FOMM) support service: results from an evaluation of a new community pharmacy service aimed at over-65s. Int J Pharm Pract. 2015;23(6):407–14.CrossRef Twigg MJ, Wright D, Barton GR, Thornley T, Kerr C. The four or more medicines (FOMM) support service: results from an evaluation of a new community pharmacy service aimed at over-65s. Int J Pharm Pract. 2015;23(6):407–14.CrossRef
18.
go back to reference Twigg G, Motsko J, Thomas J, David T. Pharmacist-managed diabetes center interventions ensure quality and safety in elderly patients. Consult Pharm. 2017;32(5):299–310.CrossRef Twigg G, Motsko J, Thomas J, David T. Pharmacist-managed diabetes center interventions ensure quality and safety in elderly patients. Consult Pharm. 2017;32(5):299–310.CrossRef
19.
go back to reference Singleton J, Veach S, Catney C, Witry M. Analysis of a community pharmacy intervention to improve low adherence rates to oral diabetes medications. Pharmacy. 2017;5(4):58.CrossRef Singleton J, Veach S, Catney C, Witry M. Analysis of a community pharmacy intervention to improve low adherence rates to oral diabetes medications. Pharmacy. 2017;5(4):58.CrossRef
20.
go back to reference Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, et al. A pharmacist telephone intervention to identify adherence barriers and improve adherence among nonadherent patients with comorbid hypertension and diabetes in a Medicare advantage plan. J Manag Care Spec Pharm. 2016;22(1):63–73.PubMed Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, et al. A pharmacist telephone intervention to identify adherence barriers and improve adherence among nonadherent patients with comorbid hypertension and diabetes in a Medicare advantage plan. J Manag Care Spec Pharm. 2016;22(1):63–73.PubMed
25.
go back to reference Närhi U, Airaksinen M, Tanskanen P, Erlund H. Therapeutic outcomes monitoring by community pharmacists for improving clinical outcomes in asthma. J Clin Pharm Ther. 2000;25(3):177–83.CrossRef Närhi U, Airaksinen M, Tanskanen P, Erlund H. Therapeutic outcomes monitoring by community pharmacists for improving clinical outcomes in asthma. J Clin Pharm Ther. 2000;25(3):177–83.CrossRef
26.
go back to reference Stuurman-Bieze AGG, Hiddink EG, van Boven JFM, Vegter S. Proactive pharmaceutical care interventions improve patients’ adherence to lipid-lowering medication. Ann Pharmacother. 2013;47(11):1448–56.CrossRef Stuurman-Bieze AGG, Hiddink EG, van Boven JFM, Vegter S. Proactive pharmaceutical care interventions improve patients’ adherence to lipid-lowering medication. Ann Pharmacother. 2013;47(11):1448–56.CrossRef
27.
go back to reference Holdford DA, Inocencio TJ. Adherence and persistence associated with an appointment-based medication synchronization program. J Am Pharm Assoc. 2013;53:576–83.CrossRef Holdford DA, Inocencio TJ. Adherence and persistence associated with an appointment-based medication synchronization program. J Am Pharm Assoc. 2013;53:576–83.CrossRef
30.
go back to reference Wright D, Twigg M, Thornley T. Chronic obstructive pulmonary disease case finding by community pharmacists: a potential cost-effective public health intervention case finding service in England, estimating costs and effects. Int J Pharm Pract. 2015;23:83–5.CrossRef Wright D, Twigg M, Thornley T. Chronic obstructive pulmonary disease case finding by community pharmacists: a potential cost-effective public health intervention case finding service in England, estimating costs and effects. Int J Pharm Pract. 2015;23:83–5.CrossRef
32.
go back to reference Rosen B, Waitzberg R, Merkur S. Israel health system review. Health Syst Transit. 2015;17(6):1–212.PubMed Rosen B, Waitzberg R, Merkur S. Israel health system review. Health Syst Transit. 2015;17(6):1–212.PubMed
35.
go back to reference Gallagher P, O'Mahony D. STOPP (screening tool of older persons’ potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with beers’ criteria. Age Ageing. 2008;37(6):673–9.CrossRef Gallagher P, O'Mahony D. STOPP (screening tool of older persons’ potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with beers’ criteria. Age Ageing. 2008;37(6):673–9.CrossRef
36.
go back to reference Aparasu RP, Mort JR. Inappropriate prescribing for the elderly: beers criteria-based review. Ann Pharmacother. 2000 Mar;34(3):338–46.CrossRef Aparasu RP, Mort JR. Inappropriate prescribing for the elderly: beers criteria-based review. Ann Pharmacother. 2000 Mar;34(3):338–46.CrossRef
39.
go back to reference State of Israel. Ministry of Health. HMO financial support of pharmaceutical counseling results: analysis result. 2017. Data on file. State of Israel. Ministry of Health. HMO financial support of pharmaceutical counseling results: analysis result. 2017. Data on file.
48.
go back to reference Triki N. The impact of rationalizing drug utilization on health outcomes. [Dissertation]. Israel: Ben Gurion University of the Negev; 2011. Hebrew Triki N. The impact of rationalizing drug utilization on health outcomes. [Dissertation]. Israel: Ben Gurion University of the Negev; 2011. Hebrew
55.
go back to reference Zwaenepoel L, Bilo R, De Boever W, De Vos WM, Reyntens J, Hoorens V, al e. Desire for information about drugs: a survey of the need for information in psychiatric in-patients. Pharm World Sci. 2005;27:47.CrossRef Zwaenepoel L, Bilo R, De Boever W, De Vos WM, Reyntens J, Hoorens V, al e. Desire for information about drugs: a survey of the need for information in psychiatric in-patients. Pharm World Sci. 2005;27:47.CrossRef
56.
go back to reference Cordina M, McElnay JC, Hughes CM. Societal perceptions of community pharmaceutical services in Malta. J Clin Pharm Ther. 1998;23(2):115–26.CrossRef Cordina M, McElnay JC, Hughes CM. Societal perceptions of community pharmaceutical services in Malta. J Clin Pharm Ther. 1998;23(2):115–26.CrossRef
57.
go back to reference Bell HM, McElnay JC, Hughes CM. Societal perspectives on the role of the community pharmacist and community based pharmacy services. J Soc Adm Pharm. 2000;17(2):119–28. Bell HM, McElnay JC, Hughes CM. Societal perspectives on the role of the community pharmacist and community based pharmacy services. J Soc Adm Pharm. 2000;17(2):119–28.
Metadata
Title
Clinical and other specialty services offered by pharmacists in the community: the international arena and Israel
Authors
Eyal Schwartzberg
Joseph P. Nathan
Sivan Avron
Eli Marom
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Israel Journal of Health Policy Research / Issue 1/2018
Electronic ISSN: 2045-4015
DOI
https://doi.org/10.1186/s13584-018-0251-y

Other articles of this Issue 1/2018

Israel Journal of Health Policy Research 1/2018 Go to the issue